The total costs to care for adult patients with heart failure will increase to $142 billion annually by 2050, according to a scientific statement published April 16 by the American Heart Association ...

Louisville, Ky.-based Baptist Health has opened a new heart failure clinic at the Baptist Health La Grange (Ky.) Ambulatory Care Center. The clinic, which began seeing patients this month, provides ...

Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Mr. A, an office worker in his late 30s, recently had a drinking party with his colleagues and drank too much. The next day, I visited the emergency room with symptoms of nausea, vomiting, hand ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

An unnamed 33-year-old Chinese suffered the classic sign of a hangover but a misdiagnosis from medics left him suffering from ...

In the UK, more than 10 per cent of the population is estimated to have some stage of chronic kidney disease and more than ...